Virus News and Research

Latest Virus News and Research

Elan agrees to restructure Tysabri collaboration with Biogen Idec

Elan Corporation, plc today announced that it has agreed to restructure the Tysabri® collaboration with Biogen Idec.

6 Feb 2013

Three NIH-sponsored influenza trials begin to enroll volunteers

Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.

6 Feb 2013

U.S. should issue formal ban on using vaccination campaigns as cover for intelligence operations

In an opinion piece in Bloomberg Businessweek's "Small World" blog, Charles Kenny, a fellow at the Center for Global Development and the New America Foundation, examines the effects of "a fake polio vaccination drive organized by the CIA in an effort to collect DNA from [Osama] bin Laden's family" on polio immunization efforts in Pakistan.

5 Feb 2013

Loyola Flu Central now available on LUHS web site

Loyola Flu Central, a weekly snapshot of flu activity locally, regionally and nationally is now available on the Loyola University Health System web site, through Twitter and on Facebook.

5 Feb 2013

India's success in fighting polio shows what country is capable of with proper funding, accountability

"India's successful war on polio shows what can happen when its government sets clear policy goals backed with proper funding and real accountability," journalist and author Dan Morrison writes in an opinion piece in the New York Times' "Latitude" blog.

5 Feb 2013

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2012.

5 Feb 2013

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Gilead Sciences today announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide sofosbuvir in combination with ribavirin (FISSION) and in combination with ribavirin and pegylated interferon (NEUTRINO) among treatment-naïve patients with chronic hepatitis C virus (HCV) infection.

5 Feb 2013

Viewpoints: Obama's 'olive branch' on birth control coverage; Sen. Kirk recounts his stroke therapy; Nurses oppose mandatory flu shots

The Obama administration released the final details Friday of the exemption it will provide religious-affiliated employers from the requirement to include free birth control in employees' insurance policies. Not surprisingly, the announcement didn't seem to mollify any of the critics who'd been arguing that the exemption was inadequate.

4 Feb 2013

Interferon retreatment warning in HCV

Hepatitis C virus patients who do not respond to interferon should not receive further treatment with the drug, say the authors of a new Cochrane review.

4 Feb 2013

Epidemiology model supports 20:80 transmission rule in HCV

A new hepatitis C virus transmission model combining genetic and epidemiologic data reveals that the majority of transmission of the virus is by a minority of intravenous drug users.

4 Feb 2013

Measles: an interview with Dr. Robert Perry, World Health Organization

Measles is a disease marked by fever, rash, and cold symptoms (red eyes, cough, runny nose) that results in a temporary suppression of the immune system and a drop in vitamin A levels.

4 Feb 2013

Scientists produce monoclonal antibody in tobacco plants that neutralizes rabies viruses

Smoking tobacco might be bad for your health, but a genetically altered version of the plant might provide a relatively inexpensive cure for the deadly rabies virus. In a new research report appearing in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants that was shown to neutralize the rabies virus.

2 Feb 2013

Study offers new evidence of natural emission of influenza

A new study suggests that patients with influenza can emit small virus-containing particles into the surrounding air during routine patient care, potentially exposing health care providers to influenza. Published in The Journal of Infectious Diseases, the findings raise the possibility that current influenza infection control recommendations may not always be adequate to protect providers from influenza during routine patient care in hospitals.

2 Feb 2013

DHEA-S may prevent neurocognitive impairment that affects AIDS patients

A team of scientists from Canada, Thailand and Morocco have found that DHEA-S may prevent neurocognitive impairment that affects a significant percentage of AIDS patients. In a report appearing in the February 2013 issue of The FASEB Journal, they describe how a network of steroid molecules found in the brain, termed "neurosteroids," is disrupted during HIV infection leading to brain damage.

2 Feb 2013

Ten common notions concerning colds and flu

The cold and flu season has hit early and hard this year. As the number of people infected continues to increase, so does the number of internet searches for ways to prevent or limit the duration of viral illnesses. But, what is fact and what is fiction?

1 Feb 2013

Current recommendations for infection control among health care providers may not be adequate

Some people with the flu emit more of the air-borne virus than others, suggesting that the current recommendations for infection control among health care providers may not be adequate, according to a new study from researchers at Wake Forest Baptist Medical Center.

1 Feb 2013

Over half of countries struggling to prevent and manage cancer

More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries’ social and economic development.

1 Feb 2013

Moderate gum disease causes severe infection and inflammation in AIDS animal model

Texas Biomed scientists in San Antonio have found that moderate gum disease in an animal model exposed to an AIDS- like virus had more viral variants causing infection and greater inflammation. Both of these features have potential negative implications in long term disease progression, including other kinds of infections, the researchers say in a new report.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

Virus News and Research

Latest Virus News and Research

Elan agrees to restructure Tysabri collaboration with Biogen Idec

Three NIH-sponsored influenza trials begin to enroll volunteers

U.S. should issue formal ban on using vaccination campaigns as cover for intelligence operations

Loyola Flu Central now available on LUHS web site

India's success in fighting polio shows what country is capable of with proper funding, accountability

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Viewpoints: Obama's 'olive branch' on birth control coverage; Sen. Kirk recounts his stroke therapy; Nurses oppose mandatory flu shots

Interferon retreatment warning in HCV

Epidemiology model supports 20:80 transmission rule in HCV

Measles: an interview with Dr. Robert Perry, World Health Organization

Scientists produce monoclonal antibody in tobacco plants that neutralizes rabies viruses

Study offers new evidence of natural emission of influenza

DHEA-S may prevent neurocognitive impairment that affects AIDS patients

Ten common notions concerning colds and flu

Current recommendations for infection control among health care providers may not be adequate

Over half of countries struggling to prevent and manage cancer

Moderate gum disease causes severe infection and inflammation in AIDS animal model

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in